View in EDS HTML Full Text PDF Full Text

Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.

Saved in:
Bibliographic Details
Title: Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.
Authors: Rollison DE; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA., Komrokji R; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA., Lee JH; c Biostatistics Core, University of New Mexico Cancer Center , Albuquerque , NM , USA., Hampras S; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA., Fulp W; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA., Fisher K; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA., Baz R; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA., Nishihori T; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA., Xu Q; e Celgene Corporation , Summit , NJ , USA., Olesnyckyj M; e Celgene Corporation , Summit , NJ , USA., Kenvin L; e Celgene Corporation , Summit , NJ , USA., Knight R; e Celgene Corporation , Summit , NJ , USA., Sullivan D; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA., Alsina M; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA., Dalton W; f DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center/M2GEN , Tampa , FL , USA., Shain KH; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2017 Mar; Vol. 58 (3), pp. 560-568. Date of Electronic Publication: 2016 Jul 18.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27424609
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rollison+DE%22">Rollison DE</searchLink>; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Komrokji+R%22">Komrokji R</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; c Biostatistics Core, University of New Mexico Cancer Center , Albuquerque , NM , USA.<br /><searchLink fieldCode="AU" term="%22Hampras+S%22">Hampras S</searchLink>; a Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Fulp+W%22">Fulp W</searchLink>; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Fisher+K%22">Fisher K</searchLink>; d Department of Biostatistics , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Baz+R%22">Baz R</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Nishihori+T%22">Nishihori T</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Xu+Q%22">Xu Q</searchLink>; e Celgene Corporation , Summit , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Olesnyckyj+M%22">Olesnyckyj M</searchLink>; e Celgene Corporation , Summit , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Kenvin+L%22">Kenvin L</searchLink>; e Celgene Corporation , Summit , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Knight+R%22">Knight R</searchLink>; e Celgene Corporation , Summit , NJ , USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+D%22">Sullivan D</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Alsina+M%22">Alsina M</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Dalton+W%22">Dalton W</searchLink>; f DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center/M2GEN , Tampa , FL , USA.<br /><searchLink fieldCode="AU" term="%22Shain+KH%22">Shain KH</searchLink>; b Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2017 Mar; Vol. 58 (3), pp. 560-568. <i>Date of Electronic Publication: </i>2016 Jul 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27424609
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2016.1207763
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 560
    Titles:
      – TitleFull: Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rollison DE
      – PersonEntity:
          Name:
            NameFull: Komrokji R
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Hampras S
      – PersonEntity:
          Name:
            NameFull: Fulp W
      – PersonEntity:
          Name:
            NameFull: Fisher K
      – PersonEntity:
          Name:
            NameFull: Baz R
      – PersonEntity:
          Name:
            NameFull: Nishihori T
      – PersonEntity:
          Name:
            NameFull: Xu Q
      – PersonEntity:
          Name:
            NameFull: Olesnyckyj M
      – PersonEntity:
          Name:
            NameFull: Kenvin L
      – PersonEntity:
          Name:
            NameFull: Knight R
      – PersonEntity:
          Name:
            NameFull: Sullivan D
      – PersonEntity:
          Name:
            NameFull: Alsina M
      – PersonEntity:
          Name:
            NameFull: Dalton W
      – PersonEntity:
          Name:
            NameFull: Shain KH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2017 Mar
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1